Risk factors for recurrent wheezing in preterm infants who received prophylaxis with palivizumab
J. bras. pneumol; 47 (5), 2021
ABSTRACT Objective: To determine the prevalence of recurrent wheezing (RW) in preterm infants who received prophylaxis against severe infection with respiratory syncytial virus (RSV) and to identify genetic susceptibility (atopy or asthma) and risk factors for RW. Methods: This was a cross-sectional st...
Antivirales/uso terapéutico, Estudios Transversales, Hospitalización, Recien Nacido Prematuro, Palivizumab/uso terapéutico, Ruidos Respiratorios, Infecciones por Virus Sincitial Respiratorio/tratamiento farmacológico, Infecciones por Virus Sincitial Respiratorio/epidemiología, Infecciones por Virus Sincitial Respiratorio/prevención & control, Factores de Riesgo